Novartis AGNVSNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR+118.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+118.9%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
50.2x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 9.21% |
| 2024 | 21.86% |
| 2023 | 1.56% |
| 2022 | -5.54% |
| 2021 | 10.41% |
| 2020 | 0.18% |
| 2019 | -4.53% |
| 2018 | 13.08% |
| 2017 | 9.99% |
| 2016 | -3.55% |